INLIF (INLF) Stock Price, News & Analysis

Company Overview

INLIF Ltd. is a holding company, which engages in the development of injection molding machine-dedicated manipulator arms. Its products include: Three-axis robot, Five-axis robot and bull head type manipulator. The company was founded on January 4, 2023 and is headquartered in Quanzhou, China.

Key Stats

• Today's Range: $4.08 to $4.67
• 50-Day Range: $3.01 to $6.90
• 52-Week Range: $3.01 to $28.00
• Volume: 22,125 shs
• Average Volume: 25,407 shs
• Market Capitalization: $57.78 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

INLIF Stock Analysis - MarketRank™

INLIF scored higher than 16% of companies evaluated by MarketBeat, and ranked 817th out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

INLIF has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

INLIF has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

INLIF has a P/B Ratio of 0.31. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.20% of the float of INLIF has been sold short.

Short Interest Ratio / Days to Cover

INLIF has a short interest ratio ("days to cover") of 1.99, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in INLIF has recently increased by 20.68%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

INLIF does not currently pay a dividend.

Dividend Growth

INLIF does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

INLIF has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for INLIF this week, compared to 1 article on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, INLIF insiders have not sold or bought any company stock.

Percentage Held by Institutions

INLIF has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 3/06/2026
• Today: 5/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Machinery
• Current Symbol: NASDAQ:INLF
• CIK: 1991592
• Web: N/A
• Phone: 086 15375760760
• Fax: N/A
• Employees: 124
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.11
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $18.41 million
• Price / Sales: 3.14
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $13.66 per share
• Price / Book: 0.31

Miscellaneous

• Outstanding Shares: 13,806,000
• Free Float: N/A
• Market Cap: $57.78 million
• Optionable: N/A
• Beta: 0.74